Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
0.7472
-0.0138 (-1.81%)
At close: Oct 26, 2026, 4:00 PM EDT
0.7487
+0.0015 (0.20%)
Pre-market: Oct 27, 2026, 4:01 AM EDT
Compass Therapeutics Market Cap
Compass Therapeutics has a market cap or net worth of $134.56 million as of October 26, 2026. It is the 23,138th most valuable company in the world and the 3,873rd biggest in the United States. Its market cap has decreased by 80.24% in one year.
Market Cap
134.56M
Enterprise Value
-35.68M
1-Year Change
-80.24%
Global Rank
Country Rank
#3,873 United States
Category
ChartMarket Cap Chart
Since April 5, 2021, Compass Therapeutics's market cap has decreased from $435.34M to $134.56M, a decrease of -69.09%. That is a compound annual growth rate of -19.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 134.56M | -85.91% |
| Dec 31, 2025 | 955.12M | 378.75% |
| Dec 31, 2024 | 199.50M | 0.34% |
| Dec 29, 2023 | 198.83M | -68.61% |
| Dec 30, 2022 | 633.47M | 105.02% |
| Dec 31, 2021 | 308.98M | -29.02% |
| Apr 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Veraxa Biotech AG | 141.41M |
| Atrium Therapeutics | 140.27M |
| Codexis | 140.17M |
| TuHURA Biosciences | 138.92M |
| Satellos Bioscience | 138.49M |
| Protara Therapeutics | 137.69M |
| Innate Pharma | 135.78M |
| Cue Biopharma | 135.55M |